The ONLY 2 BIG negatives in play and directly responsible for the depressed share price are...
1. Toronto, Ontario Canada based HQ's/facility means +90% of the USA based bio-med players still don't have IPCI on their radars unless and until they receive FDA approval on their 1st ever ANDA
2. The sheer backlog of over +2800 ANDA's currently in the FDA's pending pipeline of approvals has caused a situation where some non-compensated analysts are attempting to kick IPCI while it's down because it still hasn't received it's 1st ever FDA approval through no fault of their own whatsoever...and the only reason they'd do that is so their deep pocket friends at some firms can continue attempting to load shares from impatient hands.
Both negatives will instantly disappear soon and IPCI will never again fly as far beneath the radar as it is right now...as IPCI's ever burgeoning still completely unknown soon to be success story will be known by all the bio-med masses who continue to view IPCI as a non factor instead of the mainstream proprietary bio-med player it's prep'n to become when it busts onto the scene in a very BIG way over the next 5 to 10 years!
IPCI transforms to instant profitability on the pending FDA approval of FocalinXR & will be collecting VERY BIG upfront licensing/partnership monies on ANDA's number 2 & 3 tick tick tick tick tick>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
News 
Market Data 
Discover 
